Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
28.02
+0.04 (0.14%)
At close: Sep 18, 2026, 4:00 PM EDT
27.92
-0.10 (-0.36%)
After-hours: Sep 18, 2026, 7:34 PM EDT
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $2.48 billion as of September 18, 2026. Its market cap has decreased by -14.36% in one year.
Market Cap
2.48B
Enterprise Value
1.91B
1-Year Change
-14.36%
Ranking
Category
Stock Price
$28.02
ChartMarket Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $2.48B, an increase of 296.41%. That is a compound annual growth rate of 46.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 2.48B | -13.75% |
| Dec 31, 2025 | 2.87B | 368.78% |
| Dec 31, 2024 | 612.65M | 73.31% |
| Dec 29, 2023 | 353.50M | -43.43% |
| Feb 10, 2023 | 624.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharvaris | 2.67B |
| Disc Medicine | 2.66B |
| Nurix Therapeutics | 2.65B |
| NewAmsterdam Pharma Company | 2.62B |
| Structure Therapeutics | 2.50B |
| Harmony Biosciences Holdings | 2.49B |
| Viridian Therapeutics | 2.48B |
| Vera Therapeutics | 2.47B |